Ionis Pharmaceuticals Receives FDA Approval for ZANVASTRO, First Disease-Modifying Treatment for Alexander Disease Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) has announced that the U.S. Food and Drug Administration (FDA) has approved ZANVASTRO™ (zilganersen) for the treatment of pediatric and adult patients…
BNB Plus Appoints Three New Directors to Support Strategic Transformation and Digital Infrastructure Growth BNB Plus Corp., referred to as “BNB Plus” or the “Company,” has announced the appointment of three new members to its Board of Directors as part…
Tobias Janowitz Appointed to Lead Cancer Research at Feinstein Institutes and Northwell Health The Feinstein Institutes for Medical Research has announced the appointment of Tobias Janowitz, MD, PhD, as director of its Institute of Cancer Research, marking a significant step…
BeOne Medicines Receives FDA Approval for TEVIMBRA Combination in First-Line HER2-Positive Gastroesophageal Cancer BeOne Medicines Ltd., a global oncology-focused biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) for TEVIMBRA®…
Daiichi Sankyo Appoints Ken Keller as Chief Commercialization Officer to Accelerate Global Oncology and Specialty Medicine Growth Daiichi Sankyo has announced the appointment of Ken Keller to the newly created position of Chief Commercialization Officer, marking a significant step in…
ORZEYFUL (oveporexton) Gains Japanese Approval as the First and Only Medicine Addressing the Underlying Cause of Narcolepsy Type 1 Takeda has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved ORZEYFUL (oveporexton) for the treatment of adults…
Complete Genomics Appoints Entrepreneur and Investor Lauren Selig to Board of Directors Complete Genomics, a U.S.-based company specializing in end-to-end DNA sequencing platforms, reagents, and software, has announced the appointment of entrepreneur, investor, and film producer Lauren Selig to its…
Stuart Therapeutics Appoints David Jakeman as Chief Financial Officer to Support Late-Stage Development and Commercialization Plans Stuart Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing first-in-class collagen-reparative therapeutics for ophthalmic diseases, has announced the appointment of David Jakeman as…
Nanochon Secures Panamá Health Ministry Approval to Begin First-in-Human Chondrograft™ Clinical Study Radiation Detection Company (RDC), a long-established provider of occupational radiation dosimetry services, has announced the launch of Radiant, a real-time electronic dosimetry solution designed to provide healthcare professionals…
FDA Approves LEROCHOL Autoinjector for Once-Monthly Self-Administration in Patients With High Cholesterol LIB Therapeutics, Inc. (LIB), a privately held biopharmaceutical company focused on helping high-risk patients achieve and maintain recommended cholesterol levels, announced that the U.S. Food and Drug Administration…
U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb’s ZENBEXUS™ in Combination Therapy for Multiple Myeloma at First Relapse Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has approved ZENBEXUS™ (iberdomide) in combination with daratumumab…
Clinilabs Expands Leadership Team With Laura Shannon as CEO as Founder Gary Zammit Moves to Executive Chairperson Clinilabs, a specialty contract research organization (CRO) focused on the development of central nervous system (CNS) drugs and medical devices, has announced an…